Vericel to Present at the 40th Annual Cowen Healthcare Conference on Monday, March 2, 2020
February 24, 2020 10:04 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel to Present at the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020
February 19, 2020 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel to Report Fourth-Quarter 2019 Financial Results on February 25, 2020
February 11, 2020 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel to Present at the 22nd Annual Needham Growth Conference on Wednesday, January 15, 2020
January 09, 2020 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that...
BARDA Initiates the Procurement of NexoBrid for Emergency Response
January 06, 2020 06:30 ET
|
Vericel Corporation
YAVNE, Israel and CAMBRIDGE, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) and its U.S. commercial partner Vericel Corporation (NASDAQ: VCEL) today announced that the U.S....
Vericel Announces Appointment of Sean C. Flynn as Vice President and General Counsel
November 06, 2019 09:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel Reports Record Third Quarter Revenues, Net Income and Operating Cash Flow
November 05, 2019 08:00 ET
|
Vericel Corporation
Product Revenues of $30.5 Million Increase 36% Over Third Quarter 2018Full Year 2019 Revenue Guidance Raised to $116 to $118 MillionConference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov....
Vericel to Report Third-Quarter 2019 Financial Results on November 5, 2019
October 22, 2019 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel and MediWound Announce Initiation of U.S. NexoBrid Expanded Access Treatment Protocol
October 02, 2019 07:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass. and YAVNE, Israel, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL) and MediWound Ltd. (NASDAQ: MDWD) today announced initiation of the NexoBrid® expanded access...
Vericel to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference on Friday, October 4, 2019
September 27, 2019 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...